The chemoprevention of curcumin (7.5 μM) and tolfenamic acid (50 μM) synergistically stimulated the apoptotic effects in pancreatic cancer cells via the downregulation of survivin and suppression of specificity protein 1 (Sp1). The gene discussed is SP1; the disease is familial pancreatic carcinoma.